Teva UK and Closed Loop Medicine Collaborates to Advance Development of Personalised Medicines
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
Drug Discovery & Development | 26/03/2024 | By Manvi
Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201
Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety
Drug Discovery & Development | 26/03/2024 | By Manvi
NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004
NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.
Drug Discovery & Development | 22/03/2024 | By Manvi
Romaco Tecpharm Develops New ERS for Tablet Coaters
Romaco Tecpharm has announced the development of a new energy recovery system (ERS) for tablet coaters.
Drug Discovery & Development | 19/03/2024 | By Manvi | 118
New Marketing Code for Pharma Industry Issued by Indian Govt
The Department of Pharmaceuticals has issued a new code prohibiting pharma companies from offering gifts and travel facilities to healthcare professionals or their family members.
Drug Discovery & Development | 19/03/2024 | By Manvi
This milestone represents one of the first engineered T-cell programs targeting solid tumors to reach Phase II.
Drug Discovery & Development | 18/03/2024 | By Manvi
Biotheus will grant Hansoh Pharma a license to use the proprietary anti-EGFR/cMet bispecific antibody PM1080/HS-20117 independently developed by Biotheus for the development of antibody-drug conjugates products (ADC Product).
Drug Discovery & Development | 16/03/2024 | By Manvi
Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody
The companies have successfully completed the Good Manufacturing Practice (GMP) manufacturing of MOv18 IgE, Epsilogen’s leading IgE antibody drug candidate.
Drug Discovery & Development | 07/03/2024 | By Abha
CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction
The company’s Clean Quick Viral DNA/RNA (CE-IVD) extracts viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples preserved in an inactivating viral transport medium.
Drug Discovery & Development | 06/03/2024 | By Manvi
LTS Launches Sorrel Wearable Drug Delivery Platform with Coherus BioSciences
The platform debuts alongside Coherus' UDENYCA® on-body injector (OBI), a solution for administering pegfilgrastim-cbqv, a biosimilar pegfilgrastim utilized post-chemotherapy to mitigate infection risks.
Drug Discovery & Development | 29/02/2024 | By Manvi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy